Cyclooxygenase, NSAIDs, and colorectal cancer

Raymond N. DuBois, Walter E. Smalley

Research output: Contribution to journalReview articlepeer-review

32 Scopus citations


Prevention of human diseases has become a major focus of biomedical investigators around the world. Our current screening and treatment regimens for colorectal cancer are not effective, as indicated by the fact that this disease is the second leading cause of death from cancer in the United States. Recently published reports indicate that continuous use of aspirin reduces the relative risk of colorectal cancer by about 50%. Other work demonstrates that NSAIDs cause regression of adenomas in patients with familial adenomatous polyposis and prevent the development of colon tumors in carcinogen-treated animals. This review is a summary of the literature and includes an analysis of recent reports indicating the potential molecular basis for the chemoprotective effects of NSAIDs.

Original languageEnglish (US)
Pages (from-to)898-906
Number of pages9
JournalJournal of Gastroenterology
Issue number6
StatePublished - Dec 1996
Externally publishedYes


  • Colon cancer
  • Cyclooxygenase
  • NSAIDs
  • Prevention

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Cyclooxygenase, NSAIDs, and colorectal cancer'. Together they form a unique fingerprint.

Cite this